Celentyx Ltd seeks to appoint a Senior Business Development Executive to continue the rapid growth in sales by the company and seek partners for Celentyx’s novel mAbs, which have considerable potential as immuno-oncology and anti-inflammatory therapeutics.

The successful applicant will receive a good remuneration package with considerable opportunity for bonuses based on personal and company performance. In addition, a generous award of company share options as a ‘golden hello’ plus the potential subsequent award of company share options as part of the performance bonus.

Essential requirements:

A high level understanding of human immunology and cancer along with relevant therapeutic strategies particularly in areas of unmet need.

The commercial knowledge and understanding to help drive the growth and development of the company.

Primary location within Europe or the USA but with flexibility for long haul travel.

For initial informal discussion please contact Dr Catherine Brady (COO) via the Celentyx website (www.celentyx.com).